Coeptis Therapeutics Inc Cash Flow-to-Debt Ratio
Coeptis Therapeutics Inc cash flow-to-debt ratio. Coeptis Therapeutics Inc (COEP) has a Cash Flow-to-Debt Ratio of -0.66x as of September 2025, meaning its operating cash flow of $-2.15 Million could theoretically repay -1% of its total liabilities ($3.26 Million) in one year. Check earnings quality score of Coeptis Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Coeptis Therapeutics Inc (2004–2024)
Cash flow-to-debt ratio of Coeptis Therapeutics Inc from 2004 to 2024. Historical debt coverage capacity for Coeptis Therapeutics Inc across 9 annual periods. Check Coeptis Therapeutics Inc (COEP) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Coeptis Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2004–2024)
Coeptis Therapeutics Inc cash flow-to-debt ratio by year from 2004 to 2024. Year-by-year debt coverage analysis for Coeptis Therapeutics Inc. For the full cash flow conversion analysis, see COEP cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | $-6.65 Million | $5.04 Million | ▼ -17.8% |
| 2023 | -1.12x | $-3.88 Million | $3.46 Million | ▲ +10.1% |
| 2022 | -1.25x | $-3.88 Million | $3.11 Million | ▼ -22.5% |
| 2021 | -1.02x | $-4.49 Million | $4.41 Million | ▼ -76.5% |
| 2020 | -0.58x | $-3.14 Million | $5.44 Million | ▲ +0.3% |
| 2019 | -0.58x | $-90.07K | $155.85K | ▲ +95.7% |
| 2018 | -13.52x | $-839.06K | $62.07K | ▼ -2185.9% |
| 2005 | -0.59x | $-417.02K | $705.22K | ▼ -111.8% |
| 2004 | 5.00x | $1.55 Million | $310.94K | — |